FDA Authorizes ZYN ULTRA Pouches, Expanding Philip Morris Smoke-Free Portfolio
The FDA authorized Swedish Match USA, a Philip Morris International affiliate, to market 11 ZYN ULTRA moist oral nicotine pouch products after scientific review. The step builds on prior FDA authorizations for ZYN ULTRA 3 mg and 6 mg variants and broadens PMI’s smoke-free portfolio, supporting a long-term shift toward smoke-free offerings already available across 109 markets.